CD274 and neoplasm: Theoretically, PD-L1 expression level, neoantigen, microsatellite, tumor mutation burden, tumor heterogeneity, tumor-infiltrating lymphocytes, regulatory T cells, and damage-associated molecular patterns (DAMPs) are well-known determinants of IT responsiveness (27).